How aging affects bone health and autoimmune diseases
Sialylation of TLR2 Induces Osteoclast Fusion and Th 17 differentiation During Aging
This study is looking at how getting older might lead to autoimmune diseases like rheumatoid arthritis by exploring how certain bone cells behave, and it hopes to find new ways to help improve bone health and reduce joint pain for older adults.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11057728 on NIH RePORTER |
What this research studies
This research investigates the relationship between aging and the development of autoimmune diseases, particularly rheumatoid arthritis (RA), by focusing on the role of osteoclasts, which are cells that break down bone. The study aims to understand how the sialylation of a receptor called TLR2 influences osteoclast fusion and activity, leading to increased bone loss and joint pain. By examining the signaling mechanisms involved, the research seeks to uncover potential therapeutic targets for improving bone health in older adults. Patients may be involved in providing samples or data to help elucidate these mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for participation are adults aged 21 and older, particularly those experiencing symptoms related to autoimmune diseases or joint pain.
Not a fit: Patients who are younger than 21 or do not have any autoimmune conditions or joint pain may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or reduce bone loss and joint pain in aging populations.
How similar studies have performed: Previous research has shown promising results in understanding the role of osteoclasts in bone health, suggesting that this approach could yield significant insights.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Cao, Xu — Johns Hopkins University
- Study coordinator: Cao, Xu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.